The store will not work correctly when cookies are disabled.
5-bromo-N-tert-butyl-2-oxo-3-(2-oxoazetidin-1-yl)indoline-3-carboxamide
ID: ALA4878019
PubChem CID: 164625809
Max Phase: Preclinical
Molecular Formula: C16H18BrN3O3
Molecular Weight: 380.24
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)NC(=O)C1(N2CCC2=O)C(=O)Nc2ccc(Br)cc21
Standard InChI: InChI=1S/C16H18BrN3O3/c1-15(2,3)19-14(23)16(20-7-6-12(20)21)10-8-9(17)4-5-11(10)18-13(16)22/h4-5,8H,6-7H2,1-3H3,(H,18,22)(H,19,23)
Standard InChI Key: NRICGNAXAHIMNS-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
39.9186 -5.1797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1249 -6.0588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8017 -5.6631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0269 -6.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0257 -7.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7049 -7.4812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7031 -5.9181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3828 -6.3028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3831 -7.0929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1289 -7.3347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5920 -6.6975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3761 -6.6972 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.5617 -5.8677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7568 -5.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0036 -4.9151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.9513 -6.5455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.5732 -4.5589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.0493 -4.9213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8429 -4.0381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9736 -3.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4976 -3.4173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6020 -3.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3200 -5.8964 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
2 8 1 0
11 12 2 0
3 13 1 0
13 14 1 0
14 15 1 0
15 3 1 0
13 16 2 0
1 17 2 0
1 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
4 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 380.24 | Molecular Weight (Monoisotopic): 379.0532 | AlogP: 1.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 78.51 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.12 | CX Basic pKa: ┄ | CX LogP: 1.33 | CX LogD: 1.33 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.61 | Np Likeness Score: -0.49 |
References
1. Brandão P, López Ó, Leitzbach L, Stark H, Fernández-Bolaños JG, Burke AJ, Pineiro M.. (2021) Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors., 12 (11.0): [PMID:34795859] [10.1021/acsmedchemlett.1c00344] |